Switch to:
More From Other Websites
Teva’s Huntington Drug Hits A Snag, Lifting Rival Neurocrine May 31 2016
[$$] FDA Rejects Teva's Application For Huntington's Drug May 31 2016
FDA asks Teva Pharmaceutical for further study on Huntington's drug May 31 2016
Teva stock down 2% after FDA fails to approve new drug May 31 2016
Teva to Present at the Bernstein 32nd Annual Strategic Decisions Conference May 31 2016
FDA asks Teva Pharmaceutical for further study on Huntington drug May 31 2016
Teva Receives Complete Response Letter for NDA for SD-809 for the Treatment of Chorea Associated... May 31 2016
4:43 am Teva Pharma receives positive conclusion from European DCP for approval of BRALTUS May 31 2016
[$$] Teva investors fret over $41bn generic drugs deal May 29 2016
Allergan: Standing Out From the Pack May 27 2016
Stocks Near 5a-Week Lows May 26 2016
5 Health Care Stocks Whose Charts Tell You to Wait to Buy May 26 2016
Short Sellers Take Mixed Stance on Major Pharma May 25 2016
Valeant Pharmaceuticals: It's Complicated May 24 2016
Is This the Perfect Time to Buy Teva? May 24 2016
5 Health Care Stocks John Paulson Is Betting On in 2016 May 24 2016
Allergan to Do Smaller Deals and Boost Credit Rating May 23 2016
General Motors Company (GM): Are Hedge Funds Right Fleeing This Stock? May 23 2016
Mexico FDI rises to record high in first quarter May 23 2016
Allergan CEO says company is 'weeks away' from closing Teva deal May 23 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK